Events
Filter News
Found 121,640 articles
-
Volta Medical Announces Presentations at Heart Rhythm Society 2024 in Boston, MA, USA
4/18/2024
Volta Medical today announced presentations to be made at the Heart Rhythm Society 2024 meeting in Boston, May 16 to 19. In-person attendance and live online participation in a hybrid format will be available.
-
Renibus Therapeutics Announces Oral Presentation on RBT-1 at the European Association for Cardio-Thoracic Surgery (EACTS) 2nd Innovation Summit
4/18/2024
Renibus Therapeutics today announced an oral presentation on RBT-1 at the prestigious, invitation only, European Association for Cardio-Thoracic Surgery (EACTS) 2 nd Innovation Summit, taking place in Paris, France, April 18-20, 2024.
-
Poseida Therapeutics Announces Strong Lineup of Presentations at the American Society of Gene and Cell Therapy 27th Annual Meeting
4/18/2024
Poseida Therapeutics, Inc. today announced that six data presentations highlighting the Company's preclinical gene therapy programs and platforms will be presented at the American Society of Gene and Cell Therapy (ASGCT) 27th Annual Meeting, being held in Baltimore, MD and virtually on May 7-11, 2024.
-
Blueprint Medicines to Report First Quarter 2024 Financial Results on Thursday, May 2, 2024
4/18/2024
Blueprint Medicines Corporation (NASDAQ: BPMC) today announced that it will host a live conference call and webcast at 8:00 a.m. ET on Thursday, May 2, 2024, to report its first quarter 2024 financial results and provide a corporate update.
-
Zynex Sets First Quarter 2024 Earnings Call
4/18/2024
Zynex, Inc. will hold a conference call on Tuesday, April 30, 2024 at 4:15 PM Eastern Time to discuss its financial results for the first quarter ended March 31, 2024.
-
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
4/18/2024
Bio-Rad Laboratories, Inc. will report its financial results for the first quarter of 2024 on Tuesday, May 7, 2024, following the close of the market.
-
Ocular Therapeutix™ Announces Positive Topline Phase 1 Data for AXPAXLI™ in Diabetic Retinopathy
4/18/2024
Ocular Therapeutix, Inc. today announced positive topline results from the Phase 1 HELIOS study evaluating AXPAXLI versus a sham control in patients with moderately severe to severe non-proliferative diabetic retinopathy (‘NPDR’, NCT05695417) without diabetic macular edema (DME). Ocular plans to present the study results at an upcoming meeting.
-
SpringWorks Therapeutics to Report First Quarter 2024 Financial Results Thursday, May 2, 2024
4/18/2024
SpringWorks Therapeutics, Inc. today announced that it will host a live conference call and webcast at 8:30 a.m. E.T. on Thursday, May 2, 2024 to report its first quarter financial results and discuss recent business updates.
-
Teleflex Announces First Quarter 2024 Earnings Conference Call Information
4/18/2024
Teleflex Incorporated (NYSE:TFX) will host a conference call to discuss its first quarter financial results and provide an operational update at 8:00 a.m. Eastern Time on Thursday, May 2, 2024.
-
Aveanna Announces First Quarter 2024 Earnings Release Date and Conference Call
4/18/2024
Aveanna Healthcare Holdings Inc. today announced that the company will release its first quarter results before the market open on Thursday, May 9, 2024, to be followed by a conference call at 10:00 a.m. (Eastern Time) on the same day.
-
Agios to Webcast Conference Call of First Quarter 2024 Financial Results on May 2, 2024
4/18/2024
Agios Pharmaceuticals, Inc. today announced the company will host a conference call and live webcast on Thursday, May 2, 2024, at 8:00 a.m. ET to report its first quarter 2024 financial results and other business highlights.
-
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
4/18/2024
Arbutus Biopharma Corporation , today announced that it has scheduled its first quarter 2024 financial results and corporate update for Thursday, May 2, 2024.
-
Paratek Pharmaceuticals Presenting New Data from NUZYRA® (Omadacycline) and Investigator-Initiated Pre-Clinical Studies at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global) 2024
4/18/2024
Paratek Pharmaceuticals, Inc. today announced that three new pre-clinical studies with NUZYRA ® (omadacycline) will be presented at European Society of Clinical Microbiology & Infectious Diseases Global (ESCMID Global, formerly ECCMID).
-
Biomed 2024, Israel's Leading Annual Life Science Conference and Exhibition, May 21-23, in Tel Aviv
4/18/2024
Biomed Israel , the premier international Life Science and HealthTech conference in Israel , will take place on May 21-23, 2024 , at the David InterContinental Hotel in Tel Aviv, Israel.
-
Aesthetic Medical International to Announce FY2023 Annual Report on April 25, 2024
4/18/2024
Aesthetic Medical International Holdings Group Limited today announced that it will release its annual report for the fiscal year of 2023 after the U.S. market closes on Thursday, April 25, 2024.
-
CureVac to Report Fourth Quarter and Full-Year 2023 Financial Results and Business Update on April 24, 2024
4/18/2024
CureVac N.V. will report financial results, and provide business updates for the fourth quarter and full-year 2023 on Wednesday, April 24, 2024.
-
Tiziana Life Sciences Announces New Quantitative PET Imaging Data on Foralumab at the Annual Meeting of the American Academy of Neurology
4/18/2024
Tiziana Life Sciences, Ltd. today announces a platform presentation titled, “Treatment of PIRA with Nasal Foralumab Dampens Microglial Activation and Stabilizes Clinical Progression in Non-Active Secondary Progressive MS” at the Annual Meeting of the American Academy of Neurology in Denver, Colorado.
-
Edwards Lifesciences to Host Earnings Conference Call on April 25, 2024
4/18/2024
Edwards Lifesciences (NYSE: EW) plans to announce its operating results for the quarter ended March 31, 2024 after the market closes on Thursday, April 25, 2024, and will host a conference call at 5:00 p.m. ET that day to discuss those results.
-
Aldeyra Therapeutics to Host Research & Development Day on April 25, 2024
4/18/2024
Aldeyra Therapeutics, Inc.today announced that the company will host a Research & Development Day from 9:00a.m. to 1:00p.m. ET on Thursday, April 25, 2024 in New York City.
-
Henry Schein Supports The ‘Carry The Load’ Memorial May Campaign For Third Consecutive Year
4/18/2024
Henry Schein, Inc. (Nasdaq: HSIC) today announced that for the third consecutive year it is supporting the Carry The Load ® Memorial May campaign, a month-long Memorial Day awareness program providing active ways to connect Americans to the sacrifices made by the U.S. military, veterans.